Network pharmacology and subsequent experimental validation reveal the synergistic myocardial protection mechanism of Salvia miltiorrhiza Bge.and Carthamus tinctorius L.

Objective:To reveal the molecular mechanism underlying the compatibility of Salvia miltiorrhiza Bge(S.miltiorrhiza,Dan Shen)and C.tinctorius L.(C.tinctorius,Hong Hua)as an herb pair through network pharmacology and subsequent experimental validation.Methods:Network pharmacology was applied to construct an active ingredient-efficacy target-disease protein network to reveal the unique regulation pattern of s.miltiorrhiza and C.tinctorius as herb pair.Molecular docking was used to verify the binding of the components of these herbs and their potential targets.An H9c2 glucose hypoxia model was used to evaluate the efficacy of the components and their synergistic effects,which were evaluated using the combination index.Western blot was performed to detect the protein expression of these targets.Results:Network pharmacology analysis revealed 5 pathways and 8 core targets of s.miltiorrhiza and C.tinctorius in myocardial protection.Five of the core targets were enriched in the hypoxia-inducible factor-1(HIF-1)signaling pathway.S.miltiorrhiza-C.tinctorius achieved vascular tone mainly by regulating the target genes of the HIF-1 pathway.As an upstream gene of the HIF-1 pathway,STAT3 can be activated by the active ingredients cryptotanshinone(Ctan),salvianolic acid B(Sal.B),and myricetin(Myric).Cell experiments revealed that Myric,Sal.B,and Ctan also exhibited synergistic myocardial protective activity.Molecular docking verified the strong binding of Myric,Sal.B,and Ctan to STAT3.Western blot further showed that the active ingredients synergistically upregulated the protein expressionof STAT3.Conclusion:The pharmacodynamic transmission analysis revealed that the active ingredients of S.miltiorrhiza and C.tinctorius can synergistically resist ischemia through various targets and pathways.This study provides a methodological reference for interpreting traditional Chinese medicine compatibility.

红花S-腺苷甲硫氨酸合成酶基因的克隆与表达分析

S-腺苷甲硫氨酸合成酶(SAMS)是植物代谢过程中的一个关键酶。为了探究SAMS在红花逆境胁迫方面的作用,本研究根据红花转录组数据从红花品种豫红花1号克隆得到1个SAMS的全长cDNA序列,命名为CtSAMS1,并对其进行生物信息学分析、组织表达特性分析及非生物胁迫和激素诱导表达分析。结果表明,红花CtSAMS1基因的开放阅读框(ORF)长1173 bp,编码390个氨基酸,其蛋白分子质量为42.7 kDa,蛋白保守区预测表明CtSAMS1具有甲硫氨酸腺苷转移酶的保守结构域,属于S-腺苷甲硫氨酸合成酶家族。系统进化分析显示CtSAMS1与来自菊科的SAMS亲缘关系较近。实时荧光定量PCR(qRT-PCR)检测结果表明,CtSAMS1基因在花和茎中表达量最高,在其他组织部位中表达量极低;CtSAMS1基因表达量随着花瓣衰老程度的增加而升高。盐、干旱和低温胁迫均能够诱导CtSAMS1基因的表达,茉莉酸甲酯、水杨酸、脱落酸能够诱导红花花瓣中CtSAMS1基因表达,赤霉素对CtSAMS1基因表达有一定的抑制作用。本研究为进一步研究CtSAMS1在红花中的抗逆机制,以及为培育红花抗逆新品种奠定了理论基础。

27味中药醇提物对酪氨酸酶体外活性的影响

以儿茶酚为底物,体外分光光度法研究了22个科的27味中药醇提物对酪氨酸酶的抑制活性。结果表明,在各种中药的50%乙醇(v/v)提取液中,生药质量浓度达到2 mg/mL时,红花(Carthamus tinctoriusL.)、杨梅叶(Myrica rubraS.)、黄芩(Scutellaria baicalensisG.)和绿茶(Camellia sinensisL.)相对L-抗坏血酸(维生素C)的酪氨酸酶抑制率分别达到128.62%、83.64%、79.65%和66.48%,它们在美白化妆品领域有潜在的应用价值。

应用超滤液相色谱技术筛选中药抑制磷酸二酯酶4活性成分

本文应用超滤液相色谱技术,结合体外活性实验筛选了中药红花、土茯苓和防风中抑制磷酸二酯酶4活性成分。红花、土茯苓和防风提取物的IC50值分别为0. 03μg·μL-1,0. 06μg·μL-1和0. 05μg·μL-1,实验结果表明红花对磷酸二酯酶4具有强抑制作用,其次为防风、土茯苓。红花黄色素、落新妇苷和5-氧甲基维斯阿米苷的IC50值分别为41. 83μM,8. 11μM和3. 62μM,与磷酸二酯酶4有较好的结合能力,分别为红花、土茯苓和防风中主要抑制磷酸二酯酶-4活性成分。